- Your Strategic Partner For Regulatory Compliance
The Medical Device Single Audit Program (MDSAP) is a program that allows the conduct of a single regulatory audit of a medical device manufacturer’s quality management system that satisfies the requirements of multiple regulatory jurisdictions. Audits are conducted by Auditing Organizations authorized and recognized by the participating Regulatory Authorities to audit under MDSAP requirements.
The MDSAP is a way that medical device manufacturers can be audited once for compliance with the standard and regulatory requirements of up to five different medical device markets: Australia, Brazil, Canada, Japan and the United States. The program’s main mission is to “…jointly leverage regulatory resources to manage an efficient, effective, and sustainable single audit program focused on the oversight of medical device manufacturers.”
MDSAP was developed to reduce the burden of Regulatory audits for medical device manufacturers and to promote greater alignment of Regulatory approaches and technical requirements based on international standards and best practices. It focuses on bringing consistency, predictability, and transparency to Regulatory programs by standardizing procedures and practices of regulators and third-party auditing organizations.
The audit is based on QMS requirements under ISO 13485 and Regulatory requirements of the participating country where the medical devices will be marketed.
Any medical device manufacturer intending to market their device in the participating countries can undergo an MDSAP audit. However, each Regulatory Authority may establish exclusion criteria for certain conditions if necessary.
MDSAP is expected to significantly reduce the number of audits from different regulatory bodies that are otherwise required to demonstrate a manufacturer’s continued compliance with the QMS requirements of each MDSAP regulatory agency, saving time and reducing interruptions to manufacturing operations. Specific benefits of MDSAP include:
ISO 13485:2016 certification for your company’s QMS compliance through the MDSAP, how member countries use MDSAP:
Australia – The TGA currently uses MDSAP audit reports and certificates as part of the evidence that is assessed for compliance with medical device conformity assessment procedures and market authorization requirements, unless the medical device is otherwise excluded or exempt from these requirements or if current policies restrict the use of MDSAP audit reports.
Brazil – ANVISA currently utilizes MDSAP audit reports in their certification decision for Brazilian GMP ANVISA certificates (ANVISA inspection is not required).
Canada – MDSAP certification is required to obtain a new (or maintaining or amend an existing) Class II, III or IV medical device license.
Japan – When an MDSAP audit report is submitted at the timing of premarket or periodical post-market QMS inspection application, Japan’s Ministry of Health, Version 018 2022-08-22 Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) will use the report:
United States – U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health will accept the MDSAP audit reports as a substitute for FDA routine inspections.
Similar to other management system audit programs, MDSAP is based on a three-year audit cycle conducted in accordance with the requirements of ISO/IEC 17021:
Navigating the intricacies of MDSAP can be complex. MDR consultants offer invaluable expertise to guide you through the entire process, including:
Partnering with MDR consultants can significantly increase your chances of a successful MDSAP audit and smoother market entry for your medical devices.
Call MDR Consultants today for a free quote and to discuss how we can help you leverage MDSAP to achieve your global medical device marketing goals.
Please feel free to talk to us if you have any questions.
We endeavour to answer within 24 hours.